Biblio Discovery — Demo Discovery Service

23 hasil untuk "Kitonsa, Jonathan"

Menampilkan 1–20 · 0,44 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda

    Kiwanuka, Julius; Mukulu Waila, Jacinta; Muhindo Kahungu, Methuselah dkk.

    PLoS One · 2020 · Inggris · PubMed Central

    BACKGROUND: Retaining patients starting antiretroviral therapy (ART) and ensuring good adherence remain cornerstone of long-term viral suppression. In this era of test and treat (T&T) policy, ensuring that patients starting ART remain connected to HIV clinics is key to achieve the UNAIDS 90-90-90…

  2. Artikel Jurnal Teks lengkap

    Predictors of Loss to Follow-Up in an HIV Vaccine Preparedness Study in Masaka, Uganda

    Kabarambi, Anita; Kansiime, Sheila; Kusemererwa, Sylvia dkk.

    Int J Environ Res Public Health · 2022 · Inggris · PubMed Central

    Background: High participant retention is essential to achieve adequate statistical power for clinical trials. We assessed participant retention and predictors of loss to follow-up (LTFU) in an HIV vaccine-preparedness study in Masaka, Uganda. Methods: Between July 2018 and March 2021, HIV…

  3. Artikel Jurnal Teks lengkap

    The immediate treatment outcomes and cost estimate for managing clinical measles in children admitted at Mulago Hospital: A retrospective cohort study

    Namugga, Barbara; Malande, Ombeva; Kitonsa, Jonathan dkk.

    PLOS Glob Public Health · 2023 · Inggris · PubMed Central

    Over the recent years, the Ministry of Health in Uganda has reported multiple measles outbreaks in various districts despite the availability of a safe cost effective vaccine. Measles, especially among the unvaccinated can lead to serious complications including death while its management heavily…

  4. Artikel Jurnal Teks lengkap

    “Resilience amidst challenges”: Healthcare users’ experiences of access and utilisation of primary healthcare services during the COVID-19 pandemic in southwestern Uganda

    Kawuma, Rachel; Katongole, Joseph; Menya, Abdmagidu dkk.

    PLOS Glob Public Health · 2025 · Inggris · PubMed Central

    Primary healthcare (PHC) systems are the first point of contact for healthcare users and are critical for disease prevention and early treatment. The COVID-19 pandemic overwhelmed PHC systems globally, including in sub-Saharan Africa, significantly impacting access to essential services. We…

  5. Artikel Jurnal Teks lengkap

    Changes in self-reported risky sexual behaviour indicators among adults receiving regular risk reduction counselling and optional initiation of pre-exposure prophylaxis in an HIV vaccine preparedness study in Masaka, Uganda

    Kitonsa, Jonathan; Kansiime, Sheila; Kusemererwa, Sylvia dkk.

    Glob Health Action · 2023 · Inggris · PubMed Central

    BACKGROUND: HIV risk reduction counselling may reduce risk-taking behaviours. Yet, concerns remain about risk compensation among individuals initiating pre-exposure prophylaxis (PrEP). OBJECTIVE: We assessed changes in risky sexual behaviour indicators among HIV vaccine preparedness study…

  6. Artikel Jurnal Teks lengkap

    Factors affecting mortality among HIV positive patients two years after completing recommended therapy for Cryptococcal meningitis in Uganda

    Kitonsa, Jonathan; Mayanja, Yunia; Aling, Emmanuel dkk.

    PLoS One · 2019 · Inggris · PubMed Central

    BACKGROUND: Cryptococcal meningitis (CCM) remains a leading cause of mortality amongst HIV infected patients in sub-Saharan Africa. When patients receive recommended therapy, mortality at 10 weeks has been reported to vary between 20 to 36%. However, mortality rate and factors affecting mortality…

  7. Artikel Jurnal Teks lengkap

    Predictors of oral pre-exposure prophylaxis (PrEP) uptake among individuals in a HIV vaccine preparedness cohort in Masaka, Uganda

    Kusemererwa, Sylvia; Kansiime, Sheila; Mutonyi, Gertrude dkk.

    Medicine (Baltimore) · 2021 · Inggris · PubMed Central

    Oral pre-exposure prophylaxis (PrEP) significantly reduces human immunodeficiency virus (HIV) acquisition risk. However, data on predictors of PrEP uptake in sub-Saharan Africa are limited. We assessed predictors of PrEP uptake among HIV-uninfected high risk individuals enrolled in a HIV vaccine…

  8. Artikel Jurnal Teks lengkap

    Quality of life and associated factors among HIV positive patients after completion of treatment for Cryptococcal meningitis

    Kitonsa, Jonathan; Kiwanuka, Julius; Anywaine, Zacchaeus dkk.

    PLoS Negl Trop Dis · 2021 · Inggris · PubMed Central

    BACKGROUND: Cryptococcal meningitis (CCM) remains one of the leading causes of mortality among HIV infected patients. Due to factors such as the severity of CCM pathology, the quality of life (QOL) of patients post-treatment is likely to be poor. Few studies have reported on QOL of CCM patients…

  9. Artikel Jurnal Teks lengkap

    Determinants of two-year mortality among HIV positive patients with Cryptococcal meningitis initiating standard antifungal treatment with or without adjunctive dexamethasone in Uganda

    Kitonsa, Jonathan; Nsubuga, Rebecca; Mayanja, Yunia dkk.

    PLoS Negl Trop Dis · 2020 · Inggris · PubMed Central

    Globally, early initiation of antiretroviral therapy for HIV led to a reduction in the estimated mortality from cryptococcal meningitis (CCM) from 624,700 in 2009 to 181,100 in 2014. However, CCM remains one of the leading causes of mortality among HIV infected patients especially in sub-Saharan…

  10. Artikel Jurnal Teks lengkap

    Implementation of accelerated research: strategies for implementation as applied in a phase 1 Ad26.ZEBOV, MVA-BN-Filo two-dose Ebola vaccine clinical trial in Uganda

    Kitonsa, Jonathan; Ggayi, Abu-Baker; Anywaine, Zacchaeus dkk.

    Glob Health Action · 2020 · Inggris · PubMed Central

    BACKGROUND: The 2013–2016 Ebola epidemic in West Africa is the worst ever caused by Ebolaviruses with over 28,000 human cases and 11,325 deaths. The World Health Organisation (WHO) declared the epidemic a public health crisis that required accelerated development of novel interventions including…

  11. Artikel Jurnal Teks lengkap

    Practical application of good participatory practices for trials of emerging pathogens: Developing materials for use in ACTIV-3, -3b, and ACTIV-associated COVID-19 trials

    Guerra-de-Blas, Paola del Carmen; Marines-Price, Rubria; Milman, Olga dkk.

    J Clin Transl Sci · 2024 · Inggris · PubMed Central

    The emergence of the COVID-19 pandemic required an immediate global clinical research response. The ACTIV (Accelerating COVID-19 Therapeutic Interventions and Vaccines)-3 trials and the ACTIV-associated Outpatient Treatment with Anti-Coronavirus Immunoglobulin trial used Good Participatory…

  12. Artikel Jurnal Teks lengkap

    Willingness to participate in COVID-19 vaccine trials; a survey among a population of healthcare workers in Uganda

    Kitonsa, Jonathan; Kamacooko, Onesmus; Bahemuka, Ubaldo Mushabe dkk.

    PLoS One · 2021 · Inggris · PubMed Central

    BACKGROUND: Healthcare workers (HCWs) are at high risk of acquiring SARS-CoV-2 and COVID-19 and may therefore be a suitable population for COVID-19 vaccine trials. We conducted a survey to evaluate willingness-to-participate in COVID-19 vaccine trials in a population of HCWs at three hospitals in…

  13. Artikel Jurnal Teks lengkap

    COVID-19 Vaccine Acceptability Among Healthcare Facility Workers in Sierra Leone, the Democratic Republic of Congo and Uganda: A Multi-Centre Cross-Sectional Survey

    Whitworth, Hilary S.; Kitonsa, Jonathan; Kasonia, Kambale dkk.

    Int J Public Health · 2022 · Inggris · PubMed Central

    Objectives: This cross-sectional survey explored COVID-19 vaccine acceptability among public healthcare facility workers in Kambia (Sierra Leone), Goma (Democratic Republic of Congo) and Masaka (Uganda). Methods: Questionnaire-based interviews conducted between April–October 2021 explored…

  14. Artikel Jurnal Teks lengkap

    Knowledge, Attitudes, and Practices Regarding COVID-19 among Healthcare Workers in Uganda: A Cross-Sectional Survey

    Kamacooko, Onesmus; Kitonsa, Jonathan; Bahemuka, Ubaldo M. dkk.

    Int J Environ Res Public Health · 2021 · Inggris · PubMed Central

    Healthcare workers (HCWs) are at high risk of COVID-19. However, data on HCWs’ knowledge, attitudes, and practices (KAP) toward COVID-19 are limited. Between September and November 2020, we conducted a questionnaire-based COVID-19 KAP survey among HCWs at three hospitals in Uganda. We used Bloom’s…

  15. Artikel Jurnal Teks lengkap

    A phase I COVID-19 vaccine trial among SARS-CoV-2 seronegative and seropositive individuals in Uganda utilizing a self-amplifying RNA vaccine platform: Screening and enrollment experiences

    Kitonsa, Jonathan; Kamacooko, Onesmus; Ruzagira, Eugene dkk.

    Hum Vaccin Immunother · 2023 · Inggris · PubMed Central

    We report the screening and enrollment process for a phase I vaccine trial in Masaka, Uganda that investigated the safety and immunogenicity of a self-amplifying SARS-CoV-2 RNA vaccine amongst individuals with and without antibodies to SARS-CoV-2. Participant screening and enrollment were conducted…

  16. Artikel Jurnal Teks lengkap

    Efficacy and Safety of Long-acting Injectable Cabotegravir and Rilpivirine in Improving HIV-1 Control in sub-Saharan Africa: Protocol for a Phase 3b Open-Label Randomized Controlled Trial (IMPALA)

    Tumusiime, Victoria Babirye; Ruzagira, Eugene; Norcross, Claire dkk.

    Wellcome Open Res · 2025 · Inggris · PubMed Central

    Long-acting (LA) injectable therapy as treatment for HIV-1 infection offers reduced dosing frequency, increased discretion and provides an alternative to two or three-drug daily oral combinations. A parenteral LA formulation of cabotegravir (CAB) and rilpivirine (RPV) given by intramuscular (IM)…

  17. Artikel Jurnal Teks lengkap

    Prevalence of immunoglobulin G and M to SARS-CoV-2 and other human coronaviruses in The Democratic Republic of Congo, Sierra Leone, and Uganda: A longitudinal study

    Lawal, Bolarinde J.; Gallagher, Katherine E.; Kitonsa, Jonathan dkk.

    Int J Infect Dis · 2023 · Inggris · PubMed Central

    OBJECTIVES: We assessed the prevalence of immunoglobulin G (IgG) and IgM against four endemic human coronaviruses and two SARS-CoV-2 antigens among vaccinated and unvaccinated staff at health care centers in Uganda, Sierra Leone, and the Democratic Republic of Congo. METHODS: The government health…

  18. Artikel Jurnal Teks lengkap

    Safety and Immunogenicity of a Modified Self-Amplifying Ribonucleic Acid (saRNA) Vaccine Encoding SARS-CoV-2 Spike Glycoprotein in SARS-CoV-2 Seronegative and Seropositive Ugandan Individuals

    Kitonsa, Jonathan; Serwanga, Jennifer; Cheeseman, Hannah M. dkk.

    Vaccines (Basel) · 2025 · Inggris · PubMed Central

    Background: The COVID-19 pandemic highlighted the need for innovative vaccine platforms that elicit durable immunity. Self-amplifying RNA (saRNA) vaccines offer rapid production and dose-sparing advantages over traditional mRNA platforms. In Uganda’s first SARS-CoV-2 vaccine trial (NCT04934111), we…

  19. Artikel Jurnal Teks lengkap

    Knowledge, perceptions, uptake, and determinants of HPV vaccination, and preferred delivery strategies among out-of-school girls in Masaka, Uganda

    Kitonsa, Jonathan; Kafeero, Paddy; Ankunda, Violet dkk.

    Hum Vaccin Immunother · 2026 · Inggris · PubMed Central

    Cervical cancer is a leading cause of cancer-related mortality among women in sub-Saharan Africa, and accounts for 80% of female cancer cases in Uganda. The Human Papillomavirus (HPV) vaccine prevents cervical cancer but is mainly administered to school-going girls aged 9–15 y, potentially…

  20. Artikel Jurnal Teks lengkap

    Antiretroviral Initiation at ≥800 CD4+ Cells/mm(3) Associated With Lower Human Immunodeficiency Virus Reservoir Size

    Rasmussen, Thomas A; Ahuja, Sunil K; Kuwanda, Locadiah dkk.

    Clin Infect Dis · 2022 · Inggris · PubMed Central

    BACKGROUND: Identifying factors that determine the frequency of latently infected CD4+ T cells on antiretroviral therapy (ART) may inform strategies for human immunodeficiency virus (HIV) cure. We investigated the role of CD4+ count at ART initiation for HIV persistence on ART. METHODS: Among…